Developing Genetically and Chemically Converted Stem Cells for Cell Therapy.
Conference
·
OSTI ID:1806706
Abstract not provided.
- Research Organization:
- Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States); Sandia National Laboratories, Livermore, CA
- Sponsoring Organization:
- USDOE National Nuclear Security Administration (NNSA)
- DOE Contract Number:
- AC04-94AL85000
- OSTI ID:
- 1806706
- Report Number(s):
- SAND2018-7891C; 665947
- Country of Publication:
- United States
- Language:
- English
Similar Records
CRISPR-based Genetic Engineering of Mesenchymal Stem Cells.
Characterizing and Engineereing Mesenchymal Stem Cells for Antimicrobial Therapy.
Mesenchymal stem cell-based therapy for infectious disease.
Conference
·
Mon Jul 01 00:00:00 EDT 2019
·
OSTI ID:1641290
Characterizing and Engineereing Mesenchymal Stem Cells for Antimicrobial Therapy.
Conference
·
Thu Jan 31 23:00:00 EST 2019
·
OSTI ID:1602946
Mesenchymal stem cell-based therapy for infectious disease.
Conference
·
Mon Oct 01 00:00:00 EDT 2018
·
OSTI ID:1594331